PDP1 Knockout HAP1 Cell Line

The choice depends on whether you are studying PDP1 (pyruvate dehydrogenase phosphatase 1)'s role as the principal activator of the mitochondrial pyruvate dehydrogenase complex (PDC) or modeling its associations with PDC deficiency. The Knockout line is the standard tool for asking whether PDP1 is required for PDC activation — PDP1 dephosphorylates PDHA1 (E1α subunit) at S293, S300, and S232, opposing PDK1-4 kinases and activating PDC for pyruvate-to-acetyl-CoA flux. Overexpression is useful for studying PDP1 in metabolic stress contexts. For mitochondrial metabolism research, the EDITGENE PDP1 Knockout in HAP1 enables study of PDC regulation — PDP1 loss should phenotypically resemble PDK hyperactivation, suppressing PDC activity and promoting glycolysis over oxidative phosphorylation. PDP1 mutations cause PDC deficiency (autosomal recessive lactic acidosis with neurological dysfunction) — disease variant rescue enables genotype-function studies. Rescue with wild-type or catalytically-dead PDP1 is the standard specificity control.

Primary applications: • PDC activity: pyruvate dehydrogenase complex activity assays (NADH generation from pyruvate) to characterize PDP1-dependent PDC activation. • PDHA1 phosphorylation: phospho-PDHA1 S293/S300/S232 Western blot analysis given PDP1's role as the phosphatase opposing PDKs. • PDC deficiency modeling: rescue with patient-derived PDP1 mutations for genotype-function studies of autosomal recessive PDP1 deficiency. • Metabolic flux: ¹³C-glucose tracing into TCA cycle metabolites to characterize PDC-mediated pyruvate flux in the PDP1-null context. EDITGENE recommends this model for researchers investigating PDC regulation, PDC deficiency mechanisms, and mitochondrial pyruvate metabolism.

Yes. PDP1 rescue experiments require attention to mitochondrial targeting: • Construct design: use a codon-modified PDP1 sequence with a small C-terminal tag (FLAG, HA). PDP1 has N-terminal mitochondrial targeting sequence — N-terminal tags must not disrupt import. • Mitochondrial localization validation: confirm mitochondrial matrix localization before functional assays. • Catalytically-dead rescue: active site mutations affecting Mg²⁺ coordination (PP2C family) abolish phosphatase activity. • PDC deficiency mutation rescue: patient-derived PDP1 mutations enable disease genotype-function studies. • Functional readout: rescue should restore PDHA1 dephosphorylation and PDC activity. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.